Next Generation Protein Sequencing and Characterisation
De novo protein sequencing has become an excellent tool for commercial and non-commercial antibody research and development.
Join our upcoming webcast,presented by Rapid Novor on May 15, 2024 for exclusive insights on Next Generation Protein Sequencing and Characterisation with Monique Seymour, Senior Global Scientific Sales Executive at our principal company Rapid Novor.
In this webinar, you will learn:
- How Next Generation Protein Sequencing (NGPS) works
- Applications of NGPS to aid engineering and recombinant production of antibodies
- How REmAb® De Novo Protein Sequencing Works
Engage in thought-provoking discussions with our experts during the interactive Q&A session
Speaker Monique Seymour, MSc
Senior Scientific Sales Executive
At Rapid Novor, Monique has worked collaboratively with hundreds of scientists in both therapeutic and diagnostic fields globally to understand their goals and apply her proteomics knowledge in tandem with Rapid Novor’s REmAb® service to speed up discovery. When not at a desk or a lab, you can find her globetrotting across Europe and Asia.
If you can’t make it live, please register anyway and the recording will be sent to you, so you don’t miss out on the valuable content!